Product Information
Name:MYCi361
Brand:Biosynth
Description:MYCi361 is an antibody-drug conjugate that targets the histone deacetylase. MYCi361 has been shown to be effective in treating leukocyte antigen (HLA)-expressing tumours, such as melanoma, colorectal cancer, and breast cancer that overexpress the HER2 receptor. MYCi361 blocks the biological activity of histone deacetylase by binding to it, which results in reduced expression of HLA proteins. This leads to tumor regression and prolonged survival in animal models.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:594.9 g/mol
Formula:C26H16ClF9N2O2
Purity:Min. 95%
Technical inquiry about: MYCi361
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.